Skip to content
← Back to this collection

PUBLICATIONS · 33492986

Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02).

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2021 Mar 1
First author
Wang FH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Wang FH
      type
      Author
    2. name
      Wei XL
      type
      Author
    3. name
      Feng J
      type
      Author
    4. name
      Li Q
      type
      Author
    5. name
      Xu N
      type
      Author
    6. name
      Hu XC
      type
      Author
    7. name
      Liao W
      type
      Author
    8. name
      Jiang Y
      type
      Author
    9. name
      Lin XY
      type
      Author
    10. name
      Zhang QY
      type
      Author
    11. name
      Yuan XL
      type
      Author
    12. name
      Huang HX
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Wang FH
      type
      Author
    2. name
      Wei XL
      type
      Author
    3. name
      Feng J
      type
      Author
    4. name
      Li Q
      type
      Author
    5. name
      Xu N
      type
      Author
    6. name
      Hu XC
      type
      Author
    7. name
      Liao W
      type
      Author
    8. name
      Jiang Y
      type
      Author
    9. name
      Lin XY
      type
      Author
    10. name
      Zhang QY
      type
      Author
    11. name
      Yuan XL
      type
      Author
    12. name
      Huang HX
      type
      Author
    bibliography ids
    1. nci-bib-425bfb093caa7934b3d59ff0
    book metadata
    content sha256
    292c3524701bafaa116b1cd0ccb237667bdffedecc65761e340b358406e61cc5
    document type
    citation
    dois
    1. 10.1200/JCO.20.02712
    electronic publication date
    display
    2021 Jan 25
    precision
    day
    year
    2021
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:33492986
    immutable id
    pubmed:33492986@292c3524701bafaa116b1cd0ccb237667bdffedecc65761e340b358406e61cc5
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    7
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    704-712
    volume
    39
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      33492986
      provenance
      batch id
      9bca82d1bba2b27adc79
      provider
      NCBI PubMed ESummary
      record sha256
      d202cf48d3588989cae614a1b1105937b2562b58d5d3a67727c43aca5f392e05
      response sha256
      c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
      retrieved at
      2026-09-09T23:47:56.131551+00:00
      publication date
      display
      2021 Mar 1
      precision
      day
      year
      2021
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Multicenter Study
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/33492986/
      title
      Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02).

      Preserved source evidence · Not medical advice